Mirum Pharmaceuticals Inc (MIRM)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

950 TOWER LANE, SUITE 1050 FOSTER CITY, CA 94404

Mirum Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company develops therapies for the treating of cholestatic liver diseases. Mirum Pharmaceuticals serves patients in the United States.

Data as of 2020-07-04
Market Cap511.608 Million Shares Outstanding25.39 Million Avg 30-day Volume125.849 Thousand
P/E Ratio Dividend Yield EPS-2.4
Price/Sales Price cash flow ratio Price free cash flow ratio-10.7
Book Value6.15 Price to Tangible Book3.28 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low28.31 / 6.5126 Stddev
View SEC Filings from MIRM instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 2 0 (0.0%)
13F Filers holding this stock: 44 14 (0.92%)
Aggregate 13F shares on 03/31/2020: 18.603 Million 7.375 Million
Aggregate 13F shares on 12/31/2019: 16.249 Million 5.376 Million
Percent change: 14.49% 37.20%
Funds creating new positions: 9 5
Funds Adding to an existing position: 21 7
Funds closing out their position: 5 2
Funds reducing their position: 4 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MIRM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MIRM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NOVO HOLDINGS A/S

  • 10% Owner
0 2020-07-09 2

BREGE LAURA

  • Director
0 2020-07-02 4

MOTT DAVID M

  • Director
0 2020-07-01 2

SANDELL SCOTT D

  • 10% Owner
13,633,629 2020-07-01 2

BEHBAHANI ALI

  • Director
0 2020-07-01 2

HERON PATRICK J

  • Director
1,547,322 2020-07-01 3

NEW ENTERPRISE ASSOCIATES 16, L.P.

NEA PARTNERS 16, L.P.

NEA 16 GP, LLC

  • 10% Owner
4,294,207 2020-06-30 2

WALKER PAUL EDWARD

  • 10% Owner
4,294,207 2020-06-30 2

SONSINI PETER W.

  • 10% Owner
4,294,207 2020-06-30 2

MAKOWER JOSHUA

  • 10% Owner
4,294,207 2020-06-30 2

MAKHZOUMI MOHAMAD

  • 10% Owner
4,294,207 2020-06-30 2

FLORENCE ANTHONY A. JR.

  • 10% Owner
4,294,207 2020-06-30 2

CHANG CARMEN

  • 10% Owner
4,294,207 2020-06-30 2

BASKETT FOREST

  • 10% Owner
4,294,207 2020-06-30 2

MATHERS EDWARD T

  • Director
0 2020-06-25 2

GREY MICHAEL G

  • Director
62,290 2020-06-25 4

FISCHER LAURENT CEO AND DIRECTOR

  • Officer
  • Director
0 2020-06-15 4

O'DONNELL NIALL

  • Director
0 2020-06-11 3

BARRIS PETER J

  • Director
6,420 2020-05-27 2

RADOVICH PETER CHIEF OPERATING OFFICER

  • Officer
0 2020-04-28 2

TUCKER EDWIN JONATHAN CHIEF MEDICAL OFFICER

  • Officer
6,000 2020-03-19 4

FRAZIER LIFE SCIENCES IX, L.P.

FHMLS IX, L.P.

FHMLS IX, L.L.C.

TOPPER JAMES N

  • 10% Owner
5,009,219 2020-03-03 0

PEETZ CHRISTOPHER PRESIDENT AND CEO

  • Officer
  • Director
0 2020-01-10 3

LONGPRE LARA CHIEF DEVELOPMENT OFFICER

  • Officer
0 2020-01-10 2

VIG PAMELA CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-01-10 3

CLEMENTS IAN CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-10 3

FLYNN JAMES E

DEERFIELD MGMT HIF, L.P.

DEERFIELD MGMT IV, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

DEERFIELD MGMT L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
3,448,912 2019-07-22 2

AYNECHI TIBA

  • Director
0 2019-07-17 1

TAKEDA PHARMACEUTICAL CO LTD

SHIRE INTERNATIONAL GMBH

  • 10% Owner
1,859,151 2019-07-17 1

FLYNN JAMES E

DEERFIELD MGMT IV, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

DEERFIELD MGMT HIF, L.P.

DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
0 2019-07-17 2

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GREY MICHAEL G - Director

2020-06-11 A 17,000 a 17,000 0.00 direct

O'DONNELL NIALL - Director

2020-06-11 A 17,000 a 17,000 0.00 direct

MATHERS EDWARD T - Director

2020-06-11 A 17,000 a 17,000 0.00 direct

FISCHER LAURENT - Director

2020-06-11 A 17,000 a 17,000 0.00 direct

HERON PATRICK J - Director - > 10% Owner

2020-06-11 A 17,000 a 17,000 0.00 direct

BREGE LAURA - Director

2020-06-11 A 14,167 a 14,167 0.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments